Spinogenix
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1801 Century Park E Ste 2400, Los Angele...Phone Number
(310) 853-5695Website
www.spinogenix.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Spinogenix
Spinogenix is a clinical-stage biopharmaceutical company focused on developing innovative therapies designed to restore and repair synaptic connections in the brain. The companys research centers on addressing neurological, psychiatric, and neurodevelopmental disorders by targeting the underlying loss or dysfunction of synapses rather than only managing symptoms. Through its proprietary platform and investigational small-molecule therapies, Spinogenix aims to promote neuronal function and improve cognitive, behavioral, and motor outcomes across a range of conditions, advancing a regenerative approach to brain health and neurological care.Explore more
Spinogenix Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Spinogenix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Spinogenix has new funding data
Check if Spinogenix has recently received funding, and reach out quickly before it becomes old news!
Spinogenix, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Spinogenix
Check out if Spinogenix is spiking on competitors!
Click to see if Spinogenix had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Spinogenix recently announced quarterly report
Product Launch: Get notified when Spinogenix launches new products
Recommended Actions
Find VP level buyers at Spinogenix
Find 3 more new buyers
Compare Similar Companies to Spinogenix
Compare insights from companies similar to Spinogenix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Spinogenix is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Spinogenix is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Spinogenix.
Spinogenix financials insights
Gather financial insights about Spinogenix, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2026
Private Equity
$10.6M
Spinogenix Tech Stack
A closer look at the technologies used by Spinogenix
Spinogenix News & Media
Spinogenix Reports Positive Data on Alzheimer's Patients Who Continued Treatment With Tazbentetol For Up To 84 Weeks
Tazbentetol, a First-in-Class, Oral Synaptic Regenerative Investigational Therapy, Demonstrated Favorable Safety Profile and Durable Therapeutic Benefits Clinical Case Study Presented at AAIC Highlights Caregiver Report of Rapid Cognitive Improvement with Supporting Clinical Outcome...Spinogenix Appoints Harvard Medical School Professor of Neurology Steven E. Arnold, MD, to Scientific Advisory Board
Appointment of Renowned Alzheimer's Expert to Support Spinogenix's Advancement of Neurodegenerative Disease Strategy and Translational Biomarker Development LOS ANGELES, July 9, 2026 /PRNewswire/ -- Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering novel therapeutics...Spinogenix Appoints Professor Joseph T. Coyle, MD, Current Chair of Psychiatry and Neuroscience at Harvard Medical School, to Scientific Advisory Board
Prof. Coyle to Provide Guidance on Company's Neuroscience Pipeline, with Emphasis on Schizophrenia LOS ANGELES, July 2, 2026 /PRNewswire/ -- Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering novel therapeutics that have the potential to restore synapses to improve...Spinogenix Recognizes Dr. Craig Erickson following $17.25 Million Autism Research Grant to Cincinnati Children's Hospital
Grant Will Support Spinogenix Chief Medical Advisor's Research into Precision Medicine and EEG LOS ANGELES, June 15, 2026 /PRNewswire/ -- Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering novel therapeutics that have the potential to restore synapses to improve the...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Spinogenix
Sign Up For FreeTo access detailed company insights
Spinogenix is a clinical-stage biopharmaceutical company focused on developing innovative therapies designed to restore and repair synaptic connections in the brain. The companys research centers on addressing neurological, psychiatric, and neurodevelopmental disorders by targeting the underlying loss or dysfunction of synapses rather than only man... Read More
